Hypertrichosis aggravated and Migraine with aura

Summary:

Migraine with aura is found among people with Hypertrichosis aggravated, especially for people who are female, 50-59 old.

The study analyzes which people have Migraine with aura with Hypertrichosis aggravated. It is created by eHealthMe based on reports of 32 people who have Hypertrichosis aggravated from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hypertrichosis aggravated?

Hypertrichosis aggravated (hair growth on the body in an amount considered abnormal) is found to be associated with 379 drugs and 182 conditions by eHealthMe. Check the latest studies of Hypertrichosis aggravated.

What is Migraine with aura?

Migraine with aura (headache with vision weakness) is found to be associated with 417 drugs and 822 conditions by eHealthMe. Check the latest studies of Migraine with aura.



On Jul, 12, 2026

32 people who have Hypertrichosis Aggravated and Migraine With Aura are studied.

Would you have Migraine with aura when you have Hypertrichosis aggravated?

Gender of people who have Hypertrichosis Aggravated and experienced Migraine With Aura *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Hypertrichosis Aggravated and experienced Migraine With Aura *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 40 %
  • 40-49: 0.0 %
  • 50-59: 60 %
  • 60+: 0.0 %

Common co-existing conditions for these people *:

  1. Vaginal Bleeding Between Periods: 32 people, 100.00%
  2. Migraine (headache): 32 people, 100.00%
  3. Headache (pain in head): 32 people, 100.00%
  4. Haemorrhage (bleeding): 32 people, 100.00%
  5. Asthma: 32 people, 100.00%
  6. Dysmenorrhea (painful menstruation): 30 people, 93.75%
  7. Hair Disorder: 25 people, 78.12%
  8. Ovarian Cysts (fluid filled sacs of the ovary): 20 people, 62.50%
  9. Birth Control: 19 people, 59.38%
  10. Hair Growth Abnormal: 15 people, 46.88%

Common drugs taken by these people *:

  1. Keppra: 32 people, 100.00%
  2. Estradiol: 32 people, 100.00%
  3. Singulair: 32 people, 100.00%
  4. Almotriptan Malate: 32 people, 100.00%
  5. Amitriptyline Hydrochloride: 32 people, 100.00%
  6. Escitalopram Oxalate: 31 people, 96.88%
  7. Indomethacin: 31 people, 96.88%
  8. Topiramate: 30 people, 93.75%
  9. Paroxetine Hydrochloride: 30 people, 93.75%
  10. Dihydroergotamine Mesylate: 30 people, 93.75%

Common symptoms for these people *:

  1. Coordination Abnormal (abnormal movement): 32 people, 100.00%
  2. Dizziness: 32 people, 100.00%
  3. Mydriasis (a dilation of the pupil): 32 people, 100.00%
  4. Eyes - Bulging (swelling of eyes): 32 people, 100.00%
  5. Movement - Uncoordinated: 32 people, 100.00%
  6. Diplopia (double vision): 32 people, 100.00%
  7. Meningioma (a diverse set of tumours arising from the meninges): 32 people, 100.00%
  8. Memory Loss: 32 people, 100.00%
  9. Malaise (a feeling of general discomfort or uneasiness): 32 people, 100.00%
  10. Ligament Sprain (ligament stretched): 32 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Migraine with aura?

- Check whether Migraine with aura is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Migraine with aura:

All the conditions that are associated with Migraine with aura:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Migraine with aura and Hypertrichosis aggravated, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: